This is a review about EGFR, based on 116 published articles (read how Labome selects the articles), using EGFR antibody in all methods. It is aimed to help Labome visitors find the most suited EGFR antibody.
EGFR synonym: ERBB; ERBB1; HER1; PIG61; mENA; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; proto-oncogene c-ErbB-1; receptor tyrosine-protein kinase erbB-1

Santa Cruz BiotechnologySanta Cruz Biotechnology EGFR product
  • immunocytochemistryIn 2008, Takamitsu Sasaki et al. employed Santa Cruz Biotechnology EGFR antibody to investigate how the activation of TGFalpha-EGFR signaling in primary colon tumors contributes to the spread of tumor cells to the lymph nodes and liver [ncbi , more ]. In 2005, Jing Xu Zhu et al. used Santa Cruz Biotechnology EGFR antibody to investigate the binding of decorin to EGFR (catalog: sc-03) [ncbi , more ]. In 2004, Matthew Wherlock et al. used Santa Cruz Biotechnology EGFR antibody to detect EGFR in HeLa cells [ncbi , more ]. In 2003, Patricia A Ritch et al. utilized Santa Cruz Biotechnology EGFR antibody to study that neuregulin-1 enhances motility and migration of human astrocytic glioma cells [ncbi , more ]. In 2001, X Pesesse et al. employed Santa Cruz Biotechnology EGFR antibody to study inositol 5-phosphatase SHIP2 recruitment in EGF-stimulated COS-7 cells [ncbi , more ].
  • immunohistochemistryIn 2008, Toshio Kuwai et al. used Santa Cruz Biotechnology EGFR antibody to study whether the expression of tyrosine kinase growth factor receptors is constant or varies between and within individual colon cancer neoplasms [ncbi , more ]. In 2004, Onder Onguru et al. employed Santa Cruz Biotechnology EGFR antibody to study the role of EGFR in tumor [ncbi , more ]. In 2001, M Jost et al. used Santa Cruz Biotechnology EGFR antibody to study epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway [ncbi , more ].
  • immunoprecipitationIn 2008, Xin Zhang et al. employed Santa Cruz Biotechnology EGFR antibody to study the synergistic effect of green tea (-) epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor on inhibition of head and neck tumor growth (catalog: SC-120) [ncbi , more ]. Waltraud X Schulze et al. used Santa Cruz Biotechnology EGFR antibody to study the phosphotyrosine interactome of the ErbB-receptor kinase family [ncbi , more ] in 2005 and Chang Han et al. used Santa Cruz Biotechnology EGFR antibody to study the activation of EGFR and Akt by Cox2-derived prostaglandin E2 [ncbi , more ]. Mizuo Mifune et al. utilized Santa Cruz Biotechnology EGFR antibody to study the molecular mechanisms downstream of BTC involved in mediating vascular remodeling [ncbi , more ] in 2004 and Rafique Islam et al. used Santa Cruz Biotechnology EGFR antibody to study L1-mediated activation of EGF receptor kinase [ncbi , more ]. In 2003, Quan Lu et al. utilized Santa Cruz Biotechnology EGFR antibody to study the interaction of TSG101 and HRS [ncbi , more ]. Weidong Wu et al. applied Santa Cruz Biotechnology EGFR antibody to study phosphorylation of EGFR through zinc-induced Ras activation [ncbi , more ] in 2002 and Ziqiu Wang et al. used Santa Cruz Biotechnology EGFR antibody to study the interaction of Cdc25A with EGFR both physically and functionally in Hep3B human hepatoma cells [ncbi , more ]. Santa Cruz Biotechnology EGFR antibody was utilized in 2001 to study inositol 5-phosphatase SHIP2 recruitment in EGF-stimulated COS-7 cells [ncbi , more ], to study the role of Hrs and their interacting protein in regulating epidermal growth factor receptor degradation [ncbi , more ]and to study that the protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells (catalog: SC-03) [ncbi , more ].
  • western blotIn 2013, Uma Karthika Rajarajacholan et al. employed Santa Cruz Biotechnology EGFR antibody to perform western blot in order to study how ING1a induces senescence [ncbi , more ]. Santa Cruz Biotechnology EGFR antibody was employed in 2009 to combine computational simulations, experimental testing of simulation results, and finally reverse engineering of a protein interaction network to define potential therapeutic strategies for de novo trastuzumab resistant breast cancer (catalog: sc-03) [ncbi , more ], to carry out western blot analysis in order to investigate the role for spastin coupled with microtubule in regulating membrane traffic [ncbi , more ]and to study the mechanism underlying PKCalpha suppressing tumor in the intestine [ncbi , more ]. Santa Cruz Biotechnology EGFR antibody was utilized in 2008 to study the synergistic effect of green tea (-) epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor on inhibition of head and neck tumor growth (catalog: SC-120) [ncbi , more ], to perform western blot in order to study the expression of EGFR in SW620CE2 WT and SW620CE2 nontargeting shRNA cells [ncbi , more ], to perform western blot in order to show that active platelet-derived growth factor isoforms can control matrix remodeling of periodontal tissue [ncbi , more ], to demonstrate that Gq coupling of the AT1 receptor is essential for the EGFR transactivation and subsequent VSMC hypertrophy induced by AngII [ncbi , more ], to study the role of PAX4 in the beta-cell differentiation of human embryonic stem cells [ncbi , more ], to study the effect of S100A7-downregulation on epidermal growth factor-induced signaling in human breast cancer cells and osteoclast formation [ncbi , more ]and to perform western blot at 1:4000 dilution in order to show that Notch receptor degradation is regulated by AIP4/Itch in the absence of ligand activation [ncbi , more ]. In 2007, Ahmed E Hegab et al. employed Santa Cruz Biotechnology EGFR antibody to study the effect of niflumic acid and AG-1478 on cigarette smoke-induced mucin synthesis [ncbi , more ]. In 2006, Brian P Ceresa et al. applied Santa Cruz Biotechnology EGFR antibody to study the effect of rab7 activity on epidermal growth factor [ncbi , more ]. Santa Cruz Biotechnology EGFR antibody was employed in 2005 to study the effect of receptor-type protein-tyrosine phosphatase-kappa on epidermal growth factor receptor function [ncbi , more ], to study the function of a DnaJ domain-containing protein RME-8 in endosomal trafficking [ncbi , more ], to investigate the binding of decorin to EGFR (catalog: sc-03) [ncbi , more ], to study the role for the effect of p38 kinase on transactivation of the epidermal growth factor receptor in dedifferentiation of renal epithelial cells after oxidant injury [ncbi , more ], to detect EGF receptor in COS1 cells (catalog: sc-03) [ncbi , more ], to demonstrate that deletion of MEF GnT-V resulted in enhanced integrin clustering and activation of alpha5beta1 transcription by protein kinase C signaling [ncbi , more ], to study the biological function of protein kinase B/Akt phosphorylation [ncbi , more ]and to study RhoB protective effect from UVB-induced apoptosis in human keratinocytes [ncbi , more ]. Santa Cruz Biotechnology EGFR antibody was utilized in 2004 to detect EGFR in HeLa cells [ncbi , more ], to study the molecular mechanisms downstream of BTC involved in mediating vascular remodeling [ncbi , more ], to study the role of EGFR in tumor [ncbi , more ], to study L1-mediated activation of EGF receptor kinase [ncbi , more ], to study the role of PTEN in PDGF-induced DNA synthesis [ncbi , more ], to study the role for the sema domain of RON in ligand binding by the full-length receptor. [ncbi , more ]and to identify AMSH as an endosome-associated ubiquitin isopeptidase [ncbi , more ]. Santa Cruz Biotechnology EGFR antibody was utilized in 2003 to study the interaction of TSG101 and HRS [ncbi , more ], to study the role for PKC in controlling traffic pathway for c-Met that operates independently of its degradative pathway [ncbi , more ]and to examine ErbB1 expression levels in human bladder cancer cell lines 5637 and T24, T-47D breast cancer cells, Wild-type NIH 3T3 clone 7 mouse fibroblasts, as well as NIH 3T3 clone 7 fibroblasts overexpressing ErbB1, ErbB2, ErbB3, or ErbB4 [ncbi , more ]. Santa Cruz Biotechnology EGFR antibody was utilized in 2002 to study the production of a soluble ligand (s) of EGFR [ncbi , more ], to study the role of phosphoinositide 3-kinase beta lipid products in LPA-induced Ras activation [ncbi , more ], to study the interaction of Cdc25A with EGFR both physically and functionally in Hep3B human hepatoma cells [ncbi , more ]and to study the role for CIN85 in Cbl-b-mediated down-regulation of receptor tyrosine kinases [ncbi , more ]. Santa Cruz Biotechnology EGFR antibody was employed in 2001 to study Rap1 signaling activation in endosomes by nerve growth factor [ncbi , more ], to study inositol 5-phosphatase SHIP2 recruitment in EGF-stimulated COS-7 cells [ncbi , more ], to study the role of Hrs and their interacting protein in regulating epidermal growth factor receptor degradation [ncbi , more ]and to detect EGFR in MDCK cells and human 293T, SKBR-3 and BT20 cells [ncbi , more ].
EMD MilliporeEMD Millipore EGFR product
  • block or activateIn 2009, Carrie Hayes Sutter et al. applied EMD Millipore EGFR antibody to study the effect of EGF receptor signaling on aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes [ncbi , more ].
  • ELISAIn 2004, Vanesa Gregorc et al. employed EMD Millipore EGFR antibody to measure serum EGFR concentration [ncbi , more ].
  • immunocytochemistryIn 2006, Brian P Ceresa et al. applied EMD Millipore EGFR antibody to study the effect of rab7 activity on epidermal growth factor [ncbi , more ]. In 2005, Minji Jo et al. employed EMD Millipore EGFR antibody to study the mitogenic activity of urokinase-type plasminogen activator which is determined by the dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex [ncbi , more ]. In 2004, Anuradha Gullapalli et al. utilized EMD Millipore EGFR antibody to provide evidence for distinct functions of sorting nexin 1 and 2 in protein trafficking by investigating the role for sorting nexin 2 in epidermal growth factor receptor down-regulation [ncbi , more ]. M E Arango et al. applied EMD Millipore EGFR antibody to study sialomucin complex (rat Muc4) and receptor tyrosine kinase ErbBs in the rat lacrimal gland [ncbi , more ] in 2001 and X Chen et al. used EMD Millipore EGFR antibody to detect EGFR in human BT20 and SKBR-3 cells [ncbi , more ].
  • immunohistochemistryIn 2009, Deliang Guo et al. applied EMD Millipore EGFR antibody to investigate the mechanism of how Akt mediates sterol regulatory element-binding protein 1 (SREBP-1) cleavage induced by EGFR [ncbi , more ]. V B Thøgersen et al. used EMD Millipore EGFR antibody to study a subclass of HER1 ligands as prognostic markers for survival in bladder cancer patients [ncbi , more ] in 2001 and B Moller et al. used EMD Millipore EGFR antibody to detect EGFR in biopsies from both the anterior and posterior walls of the patients uterus [ncbi , more ].
  • immunoprecipitationIn 2005, Minji Jo et al. employed EMD Millipore EGFR antibody to study the mitogenic activity of urokinase-type plasminogen activator which is determined by the dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex [ncbi , more ]. In 2004, Chong Shan Shi et al. applied EMD Millipore EGFR antibody to study the effect of Pyk2 on epidermal growth factor and c-Src-induced Stat3 activation in HeLa cell [ncbi , more ]. In 2002, Weidong Wu et al. applied EMD Millipore EGFR antibody to study phosphorylation of EGFR through zinc-induced Ras activation [ncbi , more ].
  • western blotY Hirata et al. employed EMD Millipore EGFR antibody to demonstrate that BCL6 interacts with HB-EGF-CTF and that this interaction might induce the cyclin D2 expression in human gastric cancer [ncbi , more ] in 2009 and Jihee Kim et al. used EMD Millipore EGFR antibody to carry out immunoblotting assays in order to investigate the mechanism of ERK-dependent transactivation of the EGFR by G protein-dependent and beta-arrestin-dependent pathways in vascular smooth muscle cells [ncbi , more ]. EMD Millipore EGFR antibody was utilized in 2008 to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ], to study the role of luteinizing hormone signaling in the early activation of the EGF network [ncbi , more ]and to perform immunoblotting in order to illustrate that transforming growth factor, beta-induced (beta ig-h3/TGFBI) could enhance the aggressiveness and alter the metastatic properties of colon cancer cells in vivo [ncbi , more ]. EMD Millipore EGFR antibody was employed in 2005 to study the effect of activation of vascular endothelial growth factor receptor 3 on endothelial function and infection [ncbi , more ], to study the inhibition EGFR family members in colon and breast cancer cells [ncbi , more ], to study the mitogenic activity of urokinase-type plasminogen activator which is determined by the dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex [ncbi , more ]and to study the effect of receptor-type protein-tyrosine phosphatase-kappa on epidermal growth factor receptor function [ncbi , more ]. EMD Millipore EGFR antibody was used in 2004 to study the role of LRP-1 in beta1 integrin maturation and transportation to the cell surface [ncbi , more ], to study the regulation of TFPI-2 expression by thrombin [ncbi , more ]and to study the effect of Pyk2 on epidermal growth factor and c-Src-induced Stat3 activation in HeLa cell [ncbi , more ]. In 2002, Toshiro Niki et al. employed EMD Millipore EGFR antibody to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas [ncbi , more ]. A Schulze et al. utilized EMD Millipore EGFR antibody to study the transcriptional program induced by Raf in epithelial cells [ncbi , more ] in 2001 and B Moller et al. used EMD Millipore EGFR antibody to detect EGFR in biopsies from both the anterior and posterior walls of the patients uterus [ncbi , more ].
R and D SystemsR and D Systems EGFR product
  • ELISAIn 2010, Stefan W Stoll et al. applied R and D Systems EGFR antibody to investigate the role of EGFR ligands in the regulation of KC behavior in different cellular contexts [ncbi , more ].
  • flow cytometryIn 2008, Dominik Hartl et al. utilized R and D Systems EGFR antibody to perform western blot and flow cytometry in order to study the mechanisms that control epithelial cell AMCase secretion and its effector responses [ncbi , more ].
  • western blotIn 2008, Dominik Hartl et al. utilized R and D Systems EGFR antibody to perform western blot and flow cytometry in order to study the mechanisms that control epithelial cell AMCase secretion and its effector responses [ncbi , more ].
EpitomicsEpitomics EGFR product
  • immunohistochemistryIn 2010, Mehrnoosh Saghizadeh et al. used Epitomics EGFR antibody to perform immunohistochemistry in order to study the roles of MMP-10 and CTSF in impaired wound healing in diabetic corneas (catalog: 2342-1) [ncbi , more ].
Cell Signaling TechnologyCell Signaling Technology EGFR product
  • immunohistochemistryIn 2009, Janine A Burns et al. employed Cell Signaling Technology EGFR antibody to perform immunohistochemistry in order to study the function of the fixative in the immunohistochemical detection of phosphoproteins [ncbi , more ]. In 2008, Christina Magkou et al. used Cell Signaling Technology EGFR antibody to investigate the expressions of EGFR and pEGFR and their correlation with overall and disease-free survival, clinicopathological parameters and biological markers of invasion and angiogenesis [ncbi , more ]. In 2006, Lananh N Nguyen et al. employed Cell Signaling Technology EGFR antibody to study sorting nexin 1 down-regulation and its effect on colon tumorigenesis [ncbi , more ]. In 2004, Onder Onguru et al. employed Cell Signaling Technology EGFR antibody to study the role of EGFR in tumor [ncbi , more ].
  • immunoprecipitationIn 2009, Jihee Kim et al. used Cell Signaling Technology EGFR antibody to carry out immunoprecipitation and immunoblotting assays in order to investigate the mechanism of ERK-dependent transactivation of the EGFR by G protein-dependent and beta-arrestin-dependent pathways in vascular smooth muscle cells [ncbi , more ]. In 2008, Jiaxu Wang et al. used Cell Signaling Technology EGFR antibody to study the role of Jab1 in mediating EGFR signaling [ncbi , more ].
  • western blotLu Jiang et al. utilized Cell Signaling Technology EGFR antibody to perform western blot in order to study the role of microRNA-7 in tongue squamous cell carcinoma cells [ncbi , more ] in 2010 and Donald J Vander Griend et al. used Cell Signaling Technology EGFR antibody to investigate the role of androgen receptor signaling in the regulation of the growth of human prostate cancer initiating cells [ncbi , more ]. In 2009, Jihee Kim et al. used Cell Signaling Technology EGFR antibody to carry out immunoprecipitation and immunoblotting assays in order to investigate the mechanism of ERK-dependent transactivation of the EGFR by G protein-dependent and beta-arrestin-dependent pathways in vascular smooth muscle cells [ncbi , more ]. Cell Signaling Technology EGFR antibody was applied in 2008 to study the role of Jab1 in mediating EGFR signaling [ncbi , more ], to study the effect of S100A7-downregulation on epidermal growth factor-induced signaling in human breast cancer cells and osteoclast formation [ncbi , more ], to study the role of luteinizing hormone signaling in the early activation of the EGF network [ncbi , more ]and to study the efficacy of lapatinib for preventing the outgrowth of breast cancer cells in the brain in a mouse xenograft model of brain metastasis [ncbi , more ]. In 2007, Deshea L Harris et al. used Cell Signaling Technology EGFR antibody to study the expression and activity of PTP1B in rat corneal endothelial cells [ncbi , more ]. Cell Signaling Technology EGFR antibody was utilized in 2006 to study the role for the effect of H-REV107-1 on mitogenic signaling in growth in human non-small cell lung carcinomas [ncbi , more ], to study the effects of hypoxia on stem cell function, embryonic development, and tumor growth. [ncbi , more ], to study the link between the PI3K-Akt pathway and the cigarette smoke (CS) stimulated epidermal growth factor receptor-mediated FRA-1 induction in non-oncogenic HBE cells [ncbi , more ]and to study sorting nexin 1 down-regulation and its effect on colon tumorigenesis [ncbi , more ]. Cell Signaling Technology EGFR antibody was used in 2005 to study the effect of endothelial thrombomodulin on Ca2+ signals and nitric oxide synthesis [ncbi , more ], to study the role for the effect of p38 kinase on transactivation of the epidermal growth factor receptor in dedifferentiation of renal epithelial cells after oxidant injury [ncbi , more ]and to study the effect of receptor-type protein-tyrosine phosphatase-kappa on epidermal growth factor receptor function [ncbi , more ]. Francesca Spinella et al. employed Cell Signaling Technology EGFR antibody to study the role for endothelin-1-induced prostaglandin E2-EP2, EP4 signaling in regulating vascular endothelial growth factor production and ovarian carcinoma cell invasion [ncbi , more ] in 2004 and Onder Onguru et al. used Cell Signaling Technology EGFR antibody to study the role of EGFR in tumor [ncbi , more ]. In 2002, Weidong Wu et al. applied Cell Signaling Technology EGFR antibody to study phosphorylation of EGFR through zinc-induced Ras activation [ncbi , more ].
Enzo Life SciencesEnzo Life Sciences EGFR product
  • western blotIn 2010, Rohit Malik et al. used Enzo Life Sciences EGFR antibody to perform western blot in order to clarify that the arrestin-2/STAM-1 complex modulates CXCR4 lysosomal sorting by ubiquitination of HRS [ncbi , more ].
Life Technologies CorporationLife Technologies Corporation EGFR product
  • immunocytochemistryIn 2008, Takamitsu Sasaki et al. employed Life Technologies Corporation EGFR antibody to investigate how the activation of TGFalpha-EGFR signaling in primary colon tumors contributes to the spread of tumor cells to the lymph nodes and liver [ncbi , more ]. In 2007, Deshea L Harris et al. used Life Technologies Corporation EGFR antibody to study the expression and activity of PTP1B in rat corneal endothelial cells [ncbi , more ].
  • immunohistochemistryIn 2010, Mehrnoosh Saghizadeh et al. utilized Life Technologies Corporation EGFR antibody to perform immunohistochemistry in order to study the roles of MMP-10 and CTSF in impaired wound healing in diabetic corneas [ncbi , more ]. In 2008, Toshio Kuwai et al. used Life Technologies Corporation EGFR antibody to study whether the expression of tyrosine kinase growth factor receptors is constant or varies between and within individual colon cancer neoplasms [ncbi , more ]. In 2006, Robert B Rebhun et al. utilized Life Technologies Corporation EGFR antibody to study the role for the effect of receptor tyrosine kinase on lymphatic endothelial cells in therapy of colon cancer lymph node metastasis [ncbi , more ]. Federico Cappuzzo et al. utilized Life Technologies Corporation EGFR antibody to study epidermal growth factor receptor gene and protein and gefitinib sensitivity in non small-cell lung cancer [ncbi , more ] in 2005 and Dafydd G Thomas et al. used Life Technologies Corporation EGFR antibody to study the expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma [ncbi , more ]. In 2004, Nichon L Grupka et al. utilized Life Technologies Corporation EGFR antibody to study its status in breast cancer metastases to the central nervous system [ncbi , more ]. In 2003, Torsten O Nielsen et al. employed Life Technologies Corporation EGFR antibody to study the tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology [ncbi , more ]. In 2002, Toshiro Niki et al. employed Life Technologies Corporation EGFR antibody to study the frequent co-Localization of cox-2 and laminin-5 2 chain at the invasive front of early-stage lung adenocarcinomas [ncbi , more ].
  • immunoprecipitationIn 2004, Mizuo Mifune et al. utilized Life Technologies Corporation EGFR antibody to study the molecular mechanisms downstream of BTC involved in mediating vascular remodeling [ncbi , more ].
  • western blotIn 2009, D Chaturvedi et al. employed Life Technologies Corporation EGFR antibody to perform western blot in order to show that rapamycin treatment can lead to the transactivation of the EGFR [ncbi , more ]. In 2008, Haruhiko Ohtsu et al. employed Life Technologies Corporation EGFR antibody to demonstrate that Gq coupling of the AT1 receptor is essential for the EGFR transactivation and subsequent VSMC hypertrophy induced by AngII [ncbi , more ]. In 2007, David L Shattuck et al. used Life Technologies Corporation EGFR antibody to identify LRIG1 as a novel negative regulator of the Met receptor and its role on opposing Met and Her2 synergy [ncbi , more ]. In 2004, Mizuo Mifune et al. utilized Life Technologies Corporation EGFR antibody to study the molecular mechanisms downstream of BTC involved in mediating vascular remodeling [ncbi , more ].
Thermo Scientific Pierce ProductsThermo Scientific Pierce Products EGFR product
  • immunocytochemistryIn 2009, Jodi L Klessner et al. applied Thermo Scientific Pierce Products EGFR antibody to study the mechanism of EGFR and ADAMs cooperating to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2 [ncbi , more ]. In 2005, Jing Xu Zhu et al. applied Thermo Scientific Pierce Products EGFR antibody to investigate the binding of decorin to EGFR [ncbi , more ].
  • immunoprecipitationIn 2008, Emily J Faivre et al. applied Thermo Scientific Pierce Products EGFR antibody to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ]. In 2002, Weidong Wu et al. applied Thermo Scientific Pierce Products EGFR antibody to study phosphorylation of EGFR through zinc-induced Ras activation [ncbi , more ]. In 2001, C Sweeney et al. employed Thermo Scientific Pierce Products EGFR antibody to study growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors [ncbi , more ].
  • western blotIn 2008, Tushar B Deb et al. utilized Thermo Scientific Pierce Products EGFR antibody to perform western blot in order to study the role of calmodulin kinase in ligand-independent EGFR degradation in pregnancy [ncbi , more ]. In 2005, Jing Xu Zhu et al. applied Thermo Scientific Pierce Products EGFR antibody to investigate the binding of decorin to EGFR [ncbi , more ].
AbcamAbcam EGFR product
  • flow cytometryIn 2008, Jillian Howlin et al. used Abcam EGFR antibody to study the role of TNK2 in cancer cell invasion [ncbi , more ]. In 2004, Linda M Shearwin-Whyatt et al. employed Abcam EGFR antibody to study that N4WBP5A (Ndfip2), a Nedd4-interacting protein, localizes to multivesicular bodies and the Golgi, and has a potential role in protein trafficking [ncbi , more ].
BD BiosciencesBD Biosciences EGFR product
  • immunocytochemistryIn 2006, Paola D Vermeer et al. utilized BD Biosciences EGFR antibody to detect the localization of erbB1 in differentiated human airway epithelia [ncbi , more ].
  • immunoprecipitationIn 2003, Federica Chiara et al. employed BD Biosciences EGFR antibody to isolate epidermal growth factor receptor from human GTL16 cells [ncbi , more ].
  • western blotIn 2006, Irina Nazarenko et al. applied BD Biosciences EGFR antibody to study the role for the effect of H-REV107-1 on mitogenic signaling in growth in human non-small cell lung carcinomas [ncbi , more ]. In 2005, Stefan Kippenberger et al. applied BD Biosciences EGFR antibody to study the biological function of protein kinase B/Akt phosphorylation [ncbi , more ]. In 2003, Zubin Master et al. employed BD Biosciences EGFR antibody to study the interaction of Dok-R and c-Abl [ncbi , more ]. In 2002, Xiaodan Yu et al. used BD Biosciences EGFR antibody to study expression of p53, ErbB1, ErbB2, and Raf-1 in lung cancer [ncbi , more ].
Abgent
  • flow cytometryIn 2008, Dominik Hartl et al. utilized Abgent EGFR antibody to perform western blot and flow cytometry in order to study the mechanisms that control epithelial cell AMCase secretion and its effector responses [ncbi , more ].
  • western blotIn 2008, Dominik Hartl et al. utilized Abgent EGFR antibody to perform western blot and flow cytometry in order to study the mechanisms that control epithelial cell AMCase secretion and its effector responses [ncbi , more ].
Sigma-AldrichSigma-Aldrich EGFR product
  • immunoprecipitationIn 2003, Quan Lu et al. utilized Sigma-Aldrich EGFR antibody to study the interaction of TSG101 and HRS [ncbi , more ].
  • western blotKristen J Champion et al. used Sigma-Aldrich EGFR antibody to perform western blot in order to show that VHL tumor supppressor gene has endothelial function through fibroblast growth factor receptor signaling [ncbi , more ] in 2008 and Emily J Faivre et al. used Sigma-Aldrich EGFR antibody to study the role of progestin-stimulated rapid PR signaling in the transcriptional regulation of target genes involved in breast cancer cell proliferation [ncbi , more ]. Hila Toledano-Katchalski et al. applied Sigma-Aldrich EGFR antibody to study the dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon [ncbi , more ] in 2003 and Quan Lu et al. used Sigma-Aldrich EGFR antibody to study the interaction of TSG101 and HRS [ncbi , more ].
DakoDako EGFR product
  • immunohistochemistryIn 2010, Agnieszka Dansonka-Mieszkowska et al. employed Dako EGFR antibody to show that PALB2 mutation can increase the possibility of familial breast cancer [ncbi , more ]. Dako EGFR antibody was applied in 2008 to perform immunohistochemistry in order to study the DNA and the protein level of HER1-HER4 in 278 breast cancer patients [ncbi , more ], to perform immunohistochemistry in order to study the expression of CRYAB in breast carcinomas [ncbi , more ]and to perform immunohistochemistry in order to study the correlation of EGF and EGFR [ncbi , more ]. In 2005, Chang Han et al. employed Dako EGFR antibody to study the activation of EGFR and Akt by Cox2-derived prostaglandin E2 [ncbi , more ]. In 2004, Daniel G Hayward et al. applied Dako EGFR antibody to detect EGFR in invasive lobular carcinoma breast tumor sections [ncbi , more ]. Torsten O Nielsen et al. employed Dako EGFR antibody to study the tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology [ncbi , more ] in 2003 and A M Stark et al. used Dako EGFR antibody to study its expression in paired initial and recurrent glioblastoma multiforme [ncbi , more ].
LOXO
  • immunohistochemistryIn 2008, Felix Zeppernick et al. utilized EGFR antibody to perform immunohistochemistry in order to study the correlation between CD133 and clinical prognosis [ncbi , more ].
CARPINTERIA
  • immunohistochemistryIn 2008, Matthew Kaufman et al. utilized EGFR antibody to evaluate the expression of EGFR in a series of 16 gallbladder cancer patients from North America [ncbi , more ].
CRUK
  • western blotIn 2009, Timo Liebig et al. used EGFR antibody to study the role for RhoE in keratinocyte differentiation and stratification [ncbi , more ].
CAMBRIDGE RESEARCH
  • immunohistochemistryIn 2001, R Tamura et al. employed EGFR antibody to localize betacellulin which is a member of epidermal growth factor family in atherosclerotic plaques of human aorta [ncbi , more ].
IMCLONE SYSTEMS
  • block or activateIn 2001, J Albanell et al. utilized EGFR antibody to study the expression of activated ERK1/2 in head and neck squamous carcinoma and their relationship with EGF receptor/TGF-alpha expression [ncbi , more ].
Vector Laboratories
  • immunohistochemistryIn 2008, Christina Magkou et al. used Vector Laboratories EGFR antibody to investigate the expressions of EGFR and pEGFR and their correlation with overall and disease-free survival, clinicopathological parameters and biological markers of invasion and angiogenesis [ncbi , more ].
Biogenex
  • immunocytochemistryIn 2001, J Albanell et al. utilized Biogenex EGFR antibody to study the expression of activated ERK1/2 in head and neck squamous carcinoma and their relationship with EGF receptor/TGF-alpha expression [ncbi , more ].
  • immunohistochemistryIn 2001, J Albanell et al. utilized Biogenex EGFR antibody to study the expression of activated ERK1/2 in head and neck squamous carcinoma and their relationship with EGF receptor/TGF-alpha expression [ncbi , more ].
Genentech
  • flow cytometryIn 2004, Andrew P Mone et al. applied Genentech EGFR antibody to study the role of Hu1D10 in human chronic lymphocytic leukemia cells [ncbi , more ].
  • immunocytochemistryIn 2010, William Mike Henne et al. applied Genentech EGFR antibody to carry out immunofluorescence assays in order to investigate the roles for FCHo1 and FCHo2 proteins in clathrin-mediated endocytosis in cell plasma membrane [ncbi , more ].
Roche Applied Science
  • immunohistochemistryIn 2006, Abbas Fotovati et al. applied Roche Applied Science EGFR antibody to study the role of 17 estradiol for down-regulation of Cap43/NDRG1/Drg-1 in human breast cancer cells [ncbi , more ].
Articles Reviewed
  1. Uma Karthika Rajarajacholan et al. (2013). "The ING1a tumor suppressor regulates endocytosis to induce cellular senescence via the Rb-E2F pathway".PMID 23472054
  2. Lu Jiang et al. (2010). "MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells".PMID 20819078
  3. Rohit Malik et al. (2010). "Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CXCR4".PMID 20505072
  4. William Mike Henne et al. (2010). "FCHo proteins are nucleators of clathrin-mediated endocytosis".PMID 20448150
  5. Agnieszka Dansonka-Mieszkowska et al. (2010). "A novel germline PALB2 deletion in Polish breast and ovarian cancer patients".PMID 20122277
  6. Deliang Guo et al. (2009). "EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy".PMID 20009104
  7. Mehrnoosh Saghizadeh et al. (2010). "Adenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes".PMID 19828126
  8. Donald J Vander Griend et al. (2010). "Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells".PMID 19790235
  9. Stefan W Stoll et al. (2010). "Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin".PMID 19609315
  10. Y Hirata et al. (2009). "BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers".PMID 19337254
  11. Carrie Hayes Sutter et al. (2009). "EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes".PMID 19255421
  12. Jihee Kim et al. (2009). "Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor".PMID 19254952
  13. Marybeth A Pysz et al. (2009). "PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1".PMID 19232344
  14. D Chaturvedi et al. (2009). "Rapamycin induces transactivation of the EGFR and increases cell survival".PMID 19151764
  15. Ozgur Sahin et al. (2009). "Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance".PMID 19118495
  16. Janine A Burns et al. (2009). "Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues".PMID 19001637
  17. James W Connell et al. (2009). "Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion".PMID 19000169
  18. Jodi L Klessner et al. (2009). "EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2".PMID 18987342
  19. Timo Liebig et al. (2009). "RhoE Is required for keratinocyte differentiation and stratification".PMID 18923151
  20. Matthew Kaufman et al. (2008). "EGFR expression in gallbladder carcinoma in North America".PMID 18825277
  21. Dominik Hartl et al. (2008). "Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells".PMID 18824549
  22. Brunilde Gril et al. (2008). "Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain".PMID 18664652
  23. Patricia Chastagner et al. (2008). "AIP4/Itch regulates Notch receptor degradation in the absence of ligand".PMID 18628966
  24. Takamitsu Sasaki et al. (2008). "Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model".PMID 18583324
  25. Tushar B Deb et al. (2008). "Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation".PMID 18562482
  26. Kristen J Champion et al. (2008). "Endothelial function of von Hippel-Lindau tumor suppressor gene: control of fibroblast growth factor receptor signaling".PMID 18559510
  27. Xin Zhang et al. (2008). "Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor".PMID 18546267
  28. Jiaxu Wang et al. (2008). "Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer".PMID 18534028
  29. Christina Magkou et al. (2008). "Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas".PMID 18522728
  30. Anna Pryczynicz et al. (2008). "Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma".PMID 18505086
  31. Toshio Kuwai et al. (2008). "Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors".PMID 18472966
  32. H Agis et al. (2008). "Effects of platelet-derived growth factor isoforms on plasminogen activation by periodontal ligament and gingival fibroblasts".PMID 18447857
  33. Jillian Howlin et al. (2008). "TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells".PMID 18435854
  34. Haruhiko Ohtsu et al. (2008). "Central role of Gq in the hypertrophic signal transduction of angiotensin II in vascular smooth muscle cells".PMID 18356277
  35. Takashi Nakakuki et al. (2008). "Topological analysis of MAPK cascade for kinetic ErbB signaling".PMID 18335053
  36. Vikram Paruchuri et al. (2008). "S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation".PMID 18320059
  37. Chaoyu Ma et al. (2008). "Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation".PMID 18245446
  38. Toshio Kuwai et al. (2008). "Intratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors".PMID 18202197
  39. Emily J Faivre et al. (2008). "Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors".PMID 18202149
  40. Sara Panigone et al. (2008). "Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway".PMID 18187604
  41. Andrea Sassen et al. (2008). "Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients".PMID 18182100
  42. Felix Zeppernick et al. (2008). "Stem cell marker CD133 affects clinical outcome in glioma patients".PMID 18172261
  43. Stephanie M Sitterding et al. (2008). "AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas".PMID 18164413
  44. Deshea L Harris et al. (2007). "Protein tyrosine phosphatase, PTP1B, expression and activity in rat corneal endothelial cells".PMID 17563729
  45. Ahmed E Hegab et al. (2007). "Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1".PMID 17426222
  46. David L Shattuck et al. (2007). "LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy".PMID 17178829
  47. Lananh N Nguyen et al. (2006). "Sorting nexin 1 down-regulation promotes colon tumorigenesis".PMID 17145813
  48. Irina Nazarenko et al. (2006). "H-REV107-1 stimulates growth in non-small cell lung carcinomas via the activation of mitogenic signaling".PMID 17003497
  49. Robert B Rebhun et al. (2006). "Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis".PMID 16984732
  50. Waltraud X Schulze et al. (2005). "Phosphotyrosine interactome of the ErbB-receptor kinase family".PMID 16729043
  51. Abbas Fotovati et al. (2006). "17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells".PMID 16707596
  52. Kelly L Covello et al. (2006). "HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth".PMID 16510872
  53. Qin Zhang et al. (2006). "A Phosphatidylinositol 3-kinase-regulated Akt-independent signaling promotes cigarette smoke-induced FRA-1 expression".PMID 16490785
  54. Paola D Vermeer et al. (2006). "erbB1 functions as a sensor of airway epithelial integrity by regulation of protein phosphatase 2A activity".PMID 16293617
  55. Brian P Ceresa et al. (2006). "rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome".PMID 16282324
  56. Bruno Canguilhem et al. (2005). "RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling".PMID 16278215
  57. Yiru Xu et al. (2005). "Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function".PMID 16263724
  58. Martine Girard et al. (2005). "The DnaJ-domain protein RME-8 functions in endosomal trafficking".PMID 16179350
  59. Monique David-Dufilho et al. (2005). "Endothelial thrombomodulin induces Ca2+ signals and nitric oxide synthesis through epidermal growth factor receptor kinase and calmodulin kinase II".PMID 16126727
  60. Jing Xu Zhu et al. (2005). "Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis".PMID 15994311
  61. Xuefeng Zhang et al. (2005). "Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection".PMID 15878864
  62. Federico Cappuzzo et al. (2005). "Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer".PMID 15870435
  63. Chang Han et al. (2005). "Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt".PMID 15855163
  64. Shougang Zhuang et al. (2005). "p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury".PMID 15797859
  65. Michelle T Fodero-Tavoletti et al. (2005). "Protein tyrosine phosphatase hPTPN20a is targeted to sites of actin polymerization".PMID 15790311
  66. Hu Xu et al. (2005). "Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells".PMID 15767552
  67. Minji Jo et al. (2005). "Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator".PMID 15728176
  68. Dafydd G Thomas et al. (2005). "Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma".PMID 15641030
  69. Hua Bei Guo et al. (2005). "Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway".PMID 15615721
  70. Stefan Kippenberger et al. (2005). "Mechanical stretch stimulates protein kinase B/Akt phosphorylation in epidermal cells via angiotensin II type 1 receptor and epidermal growth factor receptor".PMID 15545271
  71. Daniel G Hayward et al. (2004). "The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer".PMID 15492258
  72. Vanesa Gregorc et al. (2004). "Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer".PMID 15447984
  73. Francesca Spinella et al. (2004). "Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion".PMID 15347673
  74. Nichon L Grupka et al. (2004). "Epidermal growth factor receptor status in breast cancer metastases to the central nervous system. Comparison with HER-2/neu status".PMID 15335267
  75. John McCullough et al. (2004). "AMSH is an endosome-associated ubiquitin isopeptidase".PMID 15314065
  76. Linda M Shearwin-Whyatt et al. (2004). "N4WBP5A (Ndfip2), a Nedd4-interacting protein, localizes to multivesicular bodies and the Golgi, and has a potential role in protein trafficking".PMID 15252135
  77. Matthew Wherlock et al. (2004). "Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase".PMID 15226397
  78. Mizuo Mifune et al. (2004). "Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells".PMID 15163624
  79. Onder Onguru et al. (2004). "Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas".PMID 15098012
  80. Anuradha Gullapalli et al. (2004). "A role for sorting nexin 2 in epidermal growth factor receptor down-regulation: evidence for distinct functions of sorting nexin 1 and 2 in protein trafficking".PMID 14978220
  81. Chong Shan Shi et al. (2004). "Pyk2 amplifies epidermal growth factor and c-Src-induced Stat3 activation".PMID 14963038
  82. Rafique Islam et al. (2004). "Activation of EGF receptor kinase by L1-mediated homophilic cell interactions".PMID 14718570
  83. Lenin Mahimainathan et al. (2004). "Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase".PMID 14718524
  84. Ana Maria Salicioni et al. (2004). "Low density lipoprotein receptor-related protein-1 promotes beta1 integrin maturation and transport to the cell surface".PMID 14699139
  85. Andrew P Mone et al. (2004). "Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells".PMID 14630799
  86. Veronique Neaud et al. (2004). "Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism".PMID 14623891
  87. Teemu T Junttila et al. (2003). "Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients".PMID 14614020
  88. Debora Angeloni et al. (2004). "The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation".PMID 14597639
  89. Torsten O Nielsen et al. (2003). "Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology".PMID 14507652
  90. Hila Toledano-Katchalski et al. (2003). "Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon".PMID 12861030
  91. Quan Lu et al. (2003). "TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation".PMID 12802020
  92. Zubin Master et al. (2003). "Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization".PMID 12777393
  93. A M Stark et al. (2003). "p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme".PMID 12754350
  94. Federica Chiara et al. (2003). "Mutations in the met oncogene unveil a "dual switch" mechanism controlling tyrosine kinase activity".PMID 12746450
  95. Stephanie Kermorgant et al. (2003). "Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met".PMID 12716900
  96. Patricia A Ritch et al. (2003). "Neuregulin-1 enhances motility and migration of human astrocytic glioma cells".PMID 12600989
  97. Iwona Szymkiewicz et al. (2002). "CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases".PMID 12177062
  98. Mihail S Iordanov et al. (2002). "The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor".PMID 12101233
  99. Weidong Wu et al. (2002). "Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine 845 is required for zinc-induced Ras activation".PMID 11983694
  100. Xiaodan Yu et al. (2002). "Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228".PMID 11929951
  101. Armelle Yart et al. (2002). "A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid".PMID 11916960
  102. Ziqiu Wang et al. (2002). "Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphatase".PMID 11912208
  103. Toshiro Niki et al. (2002). "Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas".PMID 11891209
  104. K Horsch et al. (2001). "The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells".PMID 11731619
  105. M E Arango et al. (2001). "Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland".PMID 11687512
  106. X Chen et al. (2001). "Regulation of epidermal growth factor receptor endocytosis by wortmannin through activation of Rab5 rather than inhibition of phosphatidylinositol 3-kinase".PMID 11559593
  107. J Albanell et al. (2001). "Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments".PMID 11522647
  108. V B Thøgersen et al. (2001). "A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients".PMID 11507076
  109. C Wu et al. (2001). "Nerve growth factor activates persistent Rap1 signaling in endosomes".PMID 11466412
  110. X Pesesse et al. (2001). "The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells".PMID 11349134
  111. A Schulze et al. (2001). "Analysis of the transcriptional program induced by Raf in epithelial cells".PMID 11316792
  112. C Sweeney et al. (2001). "Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors".PMID 11297548
  113. R Tamura et al. (2001). "Immunohistochemical localization of Betacellulin, a member of epidermal growth factor family, in atherosclerotic plaques of human aorta".PMID 11254912
  114. B Moller et al. (2001). "Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle".PMID 11134362
  115. L S Chin et al. (2001). "Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor".PMID 11110793
  116. M Jost et al. (2001). "Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway".PMID 11098053